BL
GILD icon

BCWM LLC’s Gilead Sciences GILD Stock Holding History

BCWM LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-61,703
Closed -$5.12M – 63
2023
Q1 		$5.12M Sell
61,703
-13,630
-18% -$1.13M 1.62% 26
2022
Q4 		$6.47M Sell
75,333
-472
-0.6% -$37.4K 2.13% 21
2022
Q3 		$4.68M Buy
75,805
+371
+0.5% +$23.4K 1.7% 25
2022
Q2 		$4.66M Buy
75,434
+16,899
+29% +$1.05M 1.59% 28
2022
Q1 		$3.48M Buy
58,535
+1,964
+3% +$126K 1.04% 40
2021
Q4 		$4.11M Buy
56,571
+566
+1% +$39K 1.21% 33
2021
Q3 		$3.91M Buy
56,005
+633
+1% +$44.5K 1.17% 32
2021
Q2 		$3.81M Buy
+55,372
New +$3.7M 1.13% 37

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCWM LLC's GILD Position: Q2 2023 in Review

BCWM LLC sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 61,703 shares — an estimated $5.12M sold.

BCWM LLC first reported a position in GILD in Q2 2021 and held it in 8 quarters. The position peaked at $6.47M in Q4 2022. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • BCWM LLC reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
  • BCWM LLC sold 61,703 Gilead Sciences shares in Q2 2023, an estimated $5.12M.
  • BCWM LLC first reported a position in Gilead Sciences in Q2 2021 and held it in 8 quarters.
  • BCWM LLC's Gilead Sciences position peaked at $6.47M in Q4 2022.
  • 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on BCWM LLC's 13F filing for Q2 2023, filed 14 Aug 2023.